What is Bortrac 3.5 Bortezomib 3.5mg Injection?
Bortezomib 3.5mg Injection Bortrac is a chemotherapy drug. Bortrac is used to treat a variety of cancers, including multiple myeloma and mantle-cell lymphoma, among others. It demonstrates its efficacy by preventing or slowing the growth of malignant growth cells in the body, demonstrating its effectiveness.
How Bortezomib 3.5mg Injection Bortrac 3.5 is used?
Bortezomib 3.5mg Injection Bortrac is administered as an intravenous infusion by a qualified clinical professional. Your primary care physician (PCP) will determine which portion is important and how frequently you should take it. This will vary depending on the condition for which you are being treated and may change on occasion. You should follow your primary care physician’s instructions to the letter. It is possible to experience severe incidental effects if you misinterpret it or take too much of it. It may take several weeks or months for you to notice or feel the benefits of this medication; however, you should not stop taking it unless your primary care physician directs you to do so.
Common Side effects of Bortezomib 3.5 MG Injection:
Exhaustion, queasiness, vomiting, and a loss of appetite are all common side effects of taking this medication. During the treatment, you will be instructed to drink plenty of fluids on a consistent basis. Because medication may cause sluggishness and discombobulation, you should avoid driving or operating heavy machinery. Platelets (red blood cells and white platelets) may be reduced by this medication, increasing your susceptibility to infection. The use of routine blood tests is required in order to examine your platelets, as well as the health of your heart, liver, and blood uric corrosive levels. For more details Click Here.
Trade Name: Bortrac
Manufacturer: Glenmark Pharmaceuticals Ltd